What is Maravai LifeSciences Holdings, Inc.'s cygnus — goodwill?

Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — goodwill of $119.93M in Q4 2025.

What does cygnus — goodwill mean?

Represents the intangible asset value recorded when the Cygnus business segment was acquired for a price exceeding the fair market value of its identifiable net assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property associated with this specific segment.

Maravai LifeSciences Holdings, Inc. (MRVI) Cygnus — Goodwill

Screener

Other segment segments

TriLink

$9.5M-76.2%

Similar metrics at other companies

STZConstellationwinesandspirits — Goodwill

$5.23B+2.1%

DYCommunications — Goodwill

$332.65M—

LENHomebuilding — Goodwill

$3.44B0.0%

COHRIndustrial — Goodwill

$3.25B—

LENMultifamily — Goodwill

$0—

CSCOAmericas — Goodwill

$36.57B+0.5%

Other financials

Income statement

See full

Revenue$51.4M+8.5%

Gross profit$20.7M+166%

Operating income-$15.1M+77.2%

Net income-$12.4M+68.6%

EPS (diluted)-$0.08+70.4%

Balance sheet

See full

Cash & equivalents$70.6M-73.8%

Total debt$176.7M-52.4%

Total equity$204.6M-23.0%

Total assets$603.7M-32.7%

Cash flow

See full

Operating cash flow$4.0M+139%

CapEx$370.0K-87.1%

Free cash flow$3.6M+128%

Valuation

See full

Market cap$918.96M+210%

Enterprise value$1.03B+158%

P/S4.4×+3.1×

Profitability

See full

Gross margin34.9%+4.4pp

Operating margin-56.1%-21.3pp

Net margin-37.1%-13.6pp

FCF margin-17.2%—

Returns & leverage

See full

Return on equity-32.9%-9.4pp

Debt / equity0.9×-0.5×

Current ratio4.1×-1.1×

Where this comes from

Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-K, filed February 26, 2026.

Filed: Feb 26, 2026, 4:06 PM EST
Fiscal year: FY2025
Accession: 0001823239-26-000011

Line item	Tri Link (1)	Cygnus (2)	Total
Balance as of December 31, 2024	$39,950	$119,928	$159,878
Acquisitions	12,207	—	12,207
Impairment	(42,884)	—	(42,884)
Foreign currency translation	228	—	228
Balance as of December 31, 2025	$9,501	$119,928	$129,429

Item 8. Financial Statements and Supplementary Data

FAQ

What is Maravai LifeSciences Holdings, Inc.'s cygnus — goodwill?: Maravai LifeSciences Holdings, Inc. (MRVI) reported cygnus — goodwill of $119.93M in Q4 2025.
What does cygnus — goodwill mean?: Represents the intangible asset value recorded when the Cygnus business segment was acquired for a price exceeding the fair market value of its identifiable net assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property associated with this specific segment.